SCHEMBL9167545

SCHEMBL9167545

Nc1c2c(nc3cc(C(F)(F)F)ccc13)CCC1(CC1)C2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 17/20 0.44
▸ BCHE P06276 11/20 0.42
▸ CHRM1 P11229 2/20 0.42
▸ EPHX2 P34913 1/20 0.42
▸ GRIN1 Q05586 7/20 0.40
▸ GRIN2A Q12879 7/20 0.40
▸ CTSD P07339 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ CACNB4 O00305 1/20 0.36
▸ CACNA1A O00555 1/20 0.36
▸ SLC22A2 O15244 1/20 0.36
▸ SLC22A1 O15245 1/20 0.36
▸ ABCC4 O15439 1/20 0.36
▸ CACNA1G O43497 1/20 0.36
▸ CACNG3 O60359 1/20 0.36
▸ CACNA1F O60840 1/20 0.36
▸ CACNA1H O95180 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ APP P05067 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10638176 0.84 ACHE (0.44) ACHEBCHECHRM1EPHX2GRIN1
SCHEMBL10351570 0.79 ACHE (0.46) ACHEBCHECHRM1EPHX2GRIN1
SCHEMBL9172823 0.77 ACHE (0.60) ACHEBCHECHRM1GRIN1GRIN2A
SCHEMBL9168192 0.77 ACHE (0.64) ACHEBCHECHRM1EPHX2GRIN1
SCHEMBL9171950 0.76 TNKS (0.46) ACHEBCHECHRM1EPHX2GRIN1
SCHEMBL9171949 0.74 ACHE (0.42) ACHEBCHECHRM1EPHX2GRIN1
SCHEMBL9163178 0.73 TNKS (0.46) ACHEBCHECHRM1EPHX2GRIN1
SCHEMBL9168172 0.73 ACHE (0.67) ACHEBCHECHRM1GRIN1GRIN2A
SCHEMBL9173696 0.72 ACHE (0.61) ACHEBCHECHRM1GRIN1GRIN2A
SCHEMBL10631817 0.72 ACHE (0.61) ACHEBCHECHRM1GRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0285018-B1 Substituted 9-Amino-Spiro [cycloalkyl[b]quinoline-2,1'cycloalkanes], a process and intermediates for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1995-05-31 — — EP disclosed
US-4806646-A Substituted 9-amino-spiro[cycloalkyl[B]quinoline-2,1'cycloalkanes] HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) 1989-02-21 — — US disclosed
US-4762841-A Substituted 9-amino-spiro(cycloalkyl(b)quinoline-2,1'cycloalkanes) HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1988-08-09 — — US disclosed
Send feedback